✉news ScienceBiology first seen 2 d ago, last 12 min ago, peak #1
Investors turn attention to bioconvergence opportunities
Original: Investing in the age of bioconvergence
Private equity publication Buyouts is examining how investors are approaching bioconvergence, the merging of biology with technology fields such as engineering, computing and materials science. The coverage signals growing interest from private markets in companies working at the intersection of life sciences and technology, as advances in biotech, AI and synthetic biology open new investment theses and funding opportunities across healthcare and industrial applications.
Why now: Investors are increasingly looking at the convergence of biology and technology as a new frontier for private-market returns.
BuyoutsPEI Private Equitybioconvergence
Rank over time, top of the chart is #1. 17 snapshots from 2 d ago to 12 min ago.
Evidence
- Investing in the age of bioconvergence · PEI Private Equity
- Investing in the age of bioconvergence · Buyouts
API: https://socialmediatrends-api.osmike.com/v1/trends/3262210